Special Access Scheme (SAS)
Overviewā
The Special Access Scheme (SAS) allows health practitioners to access therapeutic goods ā including medical devices ā that are not included in the Australian Register of Therapeutic Goods (ARTG) for specific patients who need them. SAS is an individual patient access pathway, not a general market authorisation. Each approval covers one patient or a defined patient group, not ongoing commercial supply.
SAS is established under Part 3-2 of the Therapeutic Goods Act 1989 and is the primary mechanism by which patients in Australia can access unapproved devices when no suitable approved alternative exists or when waiting for ARTG approval is not clinically appropriate.
The Three SAS Categoriesā
SAS Category A ā Seriously ill patientsā
Category A applies where a patient is seriously ill with a condition from which they are likely to die or suffer serious permanent disability, and there is no other reasonable therapeutic alternative.
Under Category A:
- The health practitioner does not need to obtain TGA approval before prescribing
- The practitioner takes responsibility for the decision to use the unapproved good
- The practitioner must notify the TGA within 28 days of first supplying the good to the patient
- The good must be supplied through a licensed wholesaler or the manufacturer
Key point: Category A is self-authorising ā the practitioner acts first and notifies afterwards. It is reserved for situations where the urgency of the patient's condition means prior TGA approval is not practical.
SAS Category B ā Application to TGA requiredā
Category B is the standard SAS pathway. The health practitioner or their institution applies to the TGA for approval before supplying the unapproved good to the patient.
Under Category B:
- Application is submitted via the TGA's online SAS portal
- The TGA assesses the application based on clinical need and available evidence
- Approval is specific to the named patient and the specified product
- TGA approval must be obtained before the device is supplied
Applications can be submitted by the treating practitioner or by an authorised delegate (such as a hospital pharmacist or regulatory affairs team).
š SAS Category B application ā TGA
SAS Category C ā Authorised supplyā
Category C allows the Secretary of the TGA to authorise certain classes of health practitioners to supply specified kinds of unapproved goods without needing individual patient approvals. This pathway is used where there is a pattern of legitimate clinical need for a product that has not yet been included in the ARTG.
Category C authorisations are product and practitioner-class specific. The TGA publishes the list of goods and practitioners covered by Category C authorisations.
What Can Be Accessed Under SASā
SAS covers unapproved therapeutic goods including:
- Medical devices not included in the ARTG
- Medical devices included in the ARTG for a different indication (off-label use in certain circumstances)
- Newer generations or models of devices not yet on the ARTG
SAS does not authorise commercial supply ā the device cannot be advertised or promoted for the unapproved use.
Sponsor and Manufacturer Obligationsā
Supplying a device under SAS does not relieve the manufacturer or supplier of all regulatory obligations. The device must:
- Still meet quality standards appropriate to the supply
- Still be manufactured under appropriate quality management conditions
- Be accompanied by adequate information for the prescriber
The importer or supplier of a device accessed under SAS may still need to hold an import licence under the Therapeutic Goods Act.
Reporting Adverse Events Under SASā
Adverse events involving devices accessed under SAS must still be reported to the TGA. The reporting obligations fall on:
- The prescribing health practitioner
- The sponsor or supplier where one exists
š Special Access Scheme ā TGA\nš SAS Category B application ā TGA\nš SAS Category C authorised supply ā TGA\nš Part 3-2 ā Therapeutic Goods Act 1989\nš Therapeutic Goods Regulations 1990ā
- Special Access Scheme ā TGA
- Part 3-2 ā Therapeutic Goods Act 1989
- SAS guidance for health practitioners ā TGA